Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-020493·Akero Therapeutics, Inc.
Schedule 13G ownership disclosure
AKERO THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 00973Y108
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RTW Investments, LP
Shares: 6,859,823 · Class: 9.8%
- Roderick Wong, M.D.
Shares: 6,859,823 · Class: 9.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-020493
- Form type
- SCHEDULE 13G/A
- Filer
- Akero Therapeutics, Inc.
- CIK
- CIK 1744659
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership